LONDON--(BUSINESS WIRE)--The global generic drugs market is expected to post a CAGR of more than 10% during the period 2018-2022, according to the latest market research report by Technavio.
A key factor driving the growth of the market is the availability of low-cost alternatives. Generic drugs are available at a lower cost when compared with branded drugs as generic drug applicants do not have to repeat the animal and clinical studies that were required to demonstrate the safety and effectiveness of brand-name medicines. Generic drug companies do not have to incur high initial drug development costs. Thus, these drugs cost about 85% lesser than their brand-name equivalents.
This market research report on the global generic drugs market 2018-2022 also provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Technavio classifies an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
In this report, Technavio highlights the advent of RPA as one of the key emerging trends in the global generic drugs market:
Global generic drugs market: Advent of RPA
The pharmaceutical companies have been using business process automation technologies such as RPA for R&D and manufacturing. RPA involves the use of software with artificial intelligence and machine learning capabilities to handle high-volume and repeatable tasks. RPA technology involves software that logs into applications, enters data, calculates and completes the necessary tasks, and logs out.
“Several companies are using AI for pharmaceutical R&D and manufacturing as digital robots can perform high-volume and repeatable tasks. The speed at which such digital robots complete the processes involved in manufacturing will allow CROs to execute recurring processes faster. This will lead to increased efficiency,” says a senior analyst at Technavio for research on cardiovascular and metabolic disorders.
Global generic drugs market: Segmentation analysis
This market research report segments the global generic drugs market by application (anti-infectives and CNS) and geography (APAC, EMEA, and the Americas).
Anti-infectives are agents that act against infections either by inhibiting the spread of an infectious agent or by destroying the infectious agent. Anti-infective drugs are required to destroy infectious agents that cause several infections in the human body such as tuberculosis, sepsis, and smallpox.
The Americas led the market in 2017 with close to 41% of the market share, followed by APAC and EMEA respectively. The Americas is expected to dominate the global market throughout the forecast period.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.
Some of the key topics covered in the report include:
Market Landscape
- Market ecosystem
- Market characteristics
- Market segmentation analysis
Market Sizing
- Market sizing
- Market size and forecast
Five Forces Analysis
Market Segmentation
Geographical Segmentation
- Regional comparison
- Key leading countries
Market Drivers
Market Challenges
Market Trends
Vendor Landscape
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at media@technavio.com.
